CLDX
Celldex Therapeutics
$29.66
−$0.49 (−1.63%)Oct 28, 2026
Key metrics
The numbers that frame CLDX today
- Market cap
- $2.33B
- Gross margin
- 100%
- EV / Sales
- 14,472.4
- ROIC
- -58.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $22.10
- 52wk High
- $45.14
Growth
Revenue and earnings trend for CLDX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CLDX
Is Celldex Therapeutics a good buy?
No. Celldex Therapeutics has strong momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Celldex Therapeutics is selling at a very high price.
What is the market capitalization of CLDX?
Celldex Therapeutics's market capitalization is $2.33B.
What is the 52-week high for CLDX stock?
The 52-week high for Celldex Therapeutics is $45.14. The current close of $29.66 is 34.3% below that high.
What is the 52-week low for CLDX stock?
The 52-week low for Celldex Therapeutics is $22.10. The current close of $29.66 is 34.2% above that low.
Does CLDX stock pay dividends?
Celldex Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CLDX?
Celldex Therapeutics's Debt / Equity ratio is 0.01.